mTuitive Future of Clincal Data Capture PathologyTNM StagingMolecular Test ReportingOpNoteAgile Author  
 
Home About mTuitive Solutions Support News Contact Us Twitter Linked In Delicious
 

* Cancer Reporting * Gross Pathology * Final Diagnosis

TNM Staging Software

Molecular Test Reporting

Operative Reporting

Services

*New* Commission on Cancer
Synoptic Reporting Requirement

A modification to Accreditation Standard 4.6 takes effect this year. In addition to requiring certain diagnostic data to be present in pathology reports, it is now required that reports use the "appropriate synoptic format."

In a letter to Cancer Program Staff in CoC-Accredited Cancer Programs dated January 28, 2009, the CoC noted the following:

For Standard 4.6, "programs will continue to include the scientifically validated data elements in the CAP protocols in the pathology reports generated by the facility. The Commendation for standard 4.6 is based on the reporting of the scientifically validated data elements using the appropriate synoptic format."

"Note that the Commendation for standard 4.6 is now based on the use of a synoptic format in the pathology reports... Surveys performed in 2010 will review pathology reports for synoptic reporting produced in 2009, which reflects this new requirement and the Commendation"

mTuitive can help your Program obtain and/or maintain accreditation quickly. xPert for Pathology is mTuitive's flagship synoptic reporting software solution that was first introduced to the market in 2002. Achieve additional valuable benefits by utilizing the system:

  • Reduces or eliminates costs associated with transcription
  • Reduces turn around time for reports
  • Ensures completeness and accuracy
  • Standardizes reporting of cancer findings for your department and registries

xPert for Pathology interfaces with all Pathology and Lab Information Systems on the market. For a demonstration or more information on achieving your Cancer Program Accreditation, please contact Mike Valentine or call 508.771.5800.

 

Email us!